CAREY STEPHEN P. 4
4 · ANI PHARMACEUTICALS INC · Filed Jun 30, 2026
Research Summary
AI-generated summary of this filing
ANIP CFO Stephen P. Carey Sells 2,850 Shares
What Happened
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals (ANIP), sold 2,850 shares in an open-market transaction on June 29, 2026. The shares were sold at a weighted average price of $84.12, producing gross proceeds of $239,742. This was a sale (disposition), not a purchase.
Key Details
- Transaction date: 2026-06-29; Form 4 filed: 2026-06-30 (timely filing).
- Prices: multiple trades at $83.39–$84.63; weighted average reported $84.12.
- Shares sold: 2,850; total proceeds: $239,742.
- Footnotes: Sale executed pursuant to a Rule 10b5-1 trading plan adopted March 6, 2026; multiple trades produced the price range and weighted average.
- Shares owned after transaction: not specified in the provided extract — see the full Form 4 for post-transaction holdings.
Context
Sales by executives can be routine (e.g., pre-planned trading plans, diversification, or tax needs). The 10b5-1 plan noted here indicates the trades were pre-scheduled, which typically limits the ability to infer sentiment from the sale alone. For investors, purchases usually carry clearer bullish signals; recorded sales like this are factual disclosures of insider activity.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-29$84.12/sh−2,850$239,742→ 177,543 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- [F2]The shares were sold in multiple trades at prices ranging from $83.39 to $84.63. The price reported above reflects the weighted average sales price.